Seven Mile Advisory’s Pfizer PFE Stock Holding History

Seven Mile Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,039	Closed	-$254K	–	188
2026 Q1	$254K	Sell	9,039 -3,380	-27%	-$90K	0.18%	128
2025 Q4	$309K	Sell	12,419 -195	-2%	-$4.92K	0.05%	167
2025 Q3	$321K	Buy	12,614 +3,200	+34%	+$79K	0.05%	193
2025 Q2	$228K	Buy	+9,414	New	+$220K	0.14%	152
2024 Q4	–	Sell	-6,938	Closed	-$201K	–	179
2024 Q3	$201K	Buy	+6,938	New	+$202K	0.13%	162
2024 Q2	–	Sell	-8,096	Closed	-$225K	–	167
2024 Q1	$225K	Sell	8,096 -2,359	-23%	-$65.5K	0.17%	132
2023 Q4	$301K	Buy	10,455 +536	+5%	+$16.2K	0.26%	88
2023 Q3	$329K	Buy	9,919 +902	+10%	+$31.9K	0.35%	69
2023 Q2	$331K	Buy	+9,017	New	+$351K	0.39%	66

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Seven Mile Advisory's PFE Position: Q2 2026 in Review

Seven Mile Advisory sold out of Pfizer (PFE) in Q2 2026, closing a stake of 9,039 shares — an estimated $254K sold.

Seven Mile Advisory first reported a position in PFE in Q2 2023 and held it in 9 quarters. The position peaked at $331K in Q2 2023. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Seven Mile Advisory reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Seven Mile Advisory sold 9,039 Pfizer shares in Q2 2026, an estimated $254K.
Seven Mile Advisory first reported a position in Pfizer in Q2 2023 and held it in 9 quarters.
Seven Mile Advisory's Pfizer position peaked at $331K in Q2 2023.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.